Hoechst Aktiengesellschaft

Peter Welzel

Gerhard Seibert

Werner Aretz

Dirk Bottger

Kurt Hobert

Alois Tumulka

Hermann Stein

Franz Kunisch

Frithjof Kruggel

Aranka Hiltmann Nee Ponty

A new Bacillus species and the appropriate enzymes obtained therefrom can be used to break down phosphoglycolipid antibiotics. The breakdown products of moenomycins display antibiotic activity or can be used as building blocks for the synthetic preparation of transglycosylase inhibitors.

Bacillus strain for breaking down moenomycins

A new microorganism for breaking down moenomycins, a process for the breakdown, and the use of the breakdown products are disclosed. A new Bacillus species and the appropriate enzymes obtained therefrom can be used to break down phosphoglycolipid antibiotics. The breakdown products of moenomycins display antibiotic activity or can be used as building blocks for the synthetic preparation of transglycosylase inhibitors.

Microorganism for breaking down moenomycins, a process for the

A new Bacillus species and the appropriate enzymes obtained therefrom can be used to break down phosphoglycolipid antibiotics. The breakdown products of moenomycins display antibiotic activity or can be used as building blocks for the synthetic preparation of transglycosylas inhibitors.

Enzymes for breaking down moenomycins

2-alkenyloxy-3-(phosphono)oxypropanoic acids derived from the cleavage

Compounds ##STR1## have valuable antibiotic activity. A method of treating microbial diseases using them is described as well.

Moenomycin a derivatives and their use as antibiotics

Growing community of inventors

Bochum, Germany

Peter Welzel